Nutritional Sciences Faculty Awarded Grant for Innovative Insparin Drug Technology Research
Nov 11, 2021
Dhurandhar and Hedge have secured a significant outside investment for research on a therapeutic drug to treat or prevent Type 1 diabetes, Type 2 diabetes, or Fatty liver disease.